Viewing nowCombinationApatri Tablet 5/80/20 milligrams
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Daehan New Pharm Co., Ltd.

MFDS item code 202006659 · Approved 2020.09.25 · Insurance code 669908030
Treatment of essential hypertension, improvement of dyslipidemia, prevention of cardiovascular disease
This medication is used for patients who need to take a combination of amlodipine, valsartan, and atorvastatin at the same time. The amlodipine/valsartan combination helps to control blood pressure in patients with essential hypertension whose blood pressure is not well controlled by monotherapy. Atorvastatin effectively reduces the risk of various cardiovascular diseases and is effective for the treatment of dyslipidemia. It is particularly used to reduce the risk of myocardial infarction, stroke, need for vascular surgery, and angina, and is also helpful for patients with diabetes and high-risk coronary artery disease. Furthermore, it improves cholesterol levels in patients with hypercholesterolemia and mixed dyslipidemia. Therefore, this medication is used to manage risk factors related to blood pressure and lipid-related diseases.
Take 1 tablet once daily with water. If possible, it is recommended to take it at the same time each day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and atorvastatin. Patients taking the amlodipine/valsartan combination together with atorvastatin as separate tablets may switch to this medicine (a combination tablet containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination It is recommended that the dose of the individual component (amlodipine or valsartan) be adjusted before administering the amlodipine/valsartan combination. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. - Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more); however, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. - Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. - Patients aged 65 years or older: Use caution when increasing the dose. ▷ Atorvastatin Before and during treatment with atorvastatin, patients should follow a standard cholesterol-lowering diet. Atorvastatin may be taken at any time of day, with or without food. 1. Dyslipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients who require a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg is for patients requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not possible. - Patients with renal impairment: No dosage adjustment is necessary because renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect. - Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult population.
This medication can cause serious harm to the fetus and neonate if taken during the second and third trimesters of pregnancy, therefore, treatment should be stopped immediately upon confirmation of pregnancy. The use of this medication should be discontinued if any muscular-related abnormal symptoms arise or if muscle damage is suspected, especially if there are risk factors like acute infections or kidney problems. This medication should not be used in patients with allergies to specific ingredients, pregnant or nursing women, or patients with severe liver or kidney conditions. Patients who are sodium or fluid deficient, patients with hyperkalemia, or patients with vascular problems in the kidneys should take this medication with special caution, regularly checking blood pressure and conducting blood tests. Patients with heart-related diseases such as heart failure or those who have had a myocardial infarction also require careful monitoring when using this medication. Dizziness or fatigue may occur during the use of this medication, and caution should be taken when driving or operating machinery. Patients with poor liver function may need to adjust their dosage and should consult a doctor immediately if symptoms of liver dysfunction appear. This medication may interact with other medications, so it is essential to inform healthcare professionals of any other medications being taken, especially antibiotics, antiviral agents, or potassium-sparing diuretics. Pregnant or nursing women should not use this medication, and women of childbearing age should use appropriate contraceptive measures while taking it. The safety of this medication for children has not been established.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. The storage temperature should be maintained between 1 to 30 degrees Celsius.
Light orange oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Daehan New Pharm Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Dongu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.